Process Design Considerations You Shouldn’t Overlook

The global demand for monoclonal antibodies (mAbs) therapeutics is not waning any time soon.

This continued growth in the mAbs market has led to demand for large capacity requirements that single-use facilities can’t support cost-effectively. Consequently, there has been very little choice but to return to stainless steel for these larger capacity facilities.

Of course, contract manufacturing organizations are taking up some of this slack as manufacturing demand outstrips current capacity. But there will still be innovator companies that continue to make investments in their facilities.

Read the article to learn four factors to keep in mind for mAb facility design and operations: https://www.pharmamanufacturing.com/articles/2022/process-design-considerations-you-shouldnt-overlook/